Graidis Spyridon, Papavramidis Theodosios S, Papaioannou Maria
Laboratory of Biological Chemistry, Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
1st Propedeutic Department of Surgery, Faculty of Health Sciences, School of Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Front Nutr. 2021 Mar 4;7:630951. doi: 10.3389/fnut.2020.630951. eCollection 2020.
Acute kidney injury (AKI) constitutes a multi-factorially caused condition, which significantly affects kidney function and can lead to elevated risk of morbidity and mortality. Given the rising scientific evidence regarding vitamin D's (VitD's) multisystemic role, the connection between AKI and VitD is currently being studied, and the complex relation between them has started to be unraveled. A systematic review had been conducted to identify the pathogenetic relation of VitD and AKI and the potential role of VitD as a biomarker and therapeutic-renoprotective factor. From 792 articles, 74 articles were identified that fulfilled the inclusion criteria. Based on these articles, it has been found that not only can VitD disorders (VitD deficiency or toxicity) cause AKI but, also, AKI can lead to great disruption in the metabolism of VitD. Moreover, it has been found that VitD serves as a novel biomarker for prediction of the risk of developing AKI and for the prognosis of AKI's severity. Finally, animal models showed that VitD can both ameliorate AKI and prevent its onset, suggesting its renoprotective effect. There is a complex two-way pathogenetic relation between VitD disorders and AKI, while, concomitantly, VitD serves as a potential novel predictive-prognostic biomarker and a treatment agent in AKI therapy.
急性肾损伤(AKI)是一种由多种因素引起的病症,它会显著影响肾功能,并可能导致发病和死亡风险升高。鉴于有关维生素D(VitD)多系统作用的科学证据不断增加,目前正在研究AKI与VitD之间的联系,它们之间的复杂关系也已开始被揭示。已进行了一项系统综述,以确定VitD与AKI的发病机制关系以及VitD作为生物标志物和治疗性肾脏保护因子的潜在作用。从792篇文章中,筛选出74篇符合纳入标准的文章。基于这些文章发现,不仅VitD紊乱(VitD缺乏或中毒)会导致AKI,而且AKI也会导致VitD代谢的严重紊乱。此外,还发现VitD可作为预测发生AKI风险和AKI严重程度预后的新型生物标志物。最后,动物模型表明,VitD既能改善AKI,又能预防其发生,提示其具有肾脏保护作用。VitD紊乱与AKI之间存在复杂的双向发病机制关系,同时,VitD在AKI治疗中作为一种潜在的新型预测-预后生物标志物和治疗药物。